Smart Cancer Patch: AI-Integrated Biosensor with Adaptive Drug Release for Universal Cancer Detection and Treatment

Cancer continues to be one of the leading causes of death worldwide, and late-stage detection remains a significant challenge in clinical oncology. Early detection of cancer, especially in asymptomatic stages, has the potential to significantly improve survival rates by facilitating timely intervention. However, conventional methods such as biopsies, CT scans, and blood tests are invasive, expensive, and often unable to detect cancer early enough. This paper proposes a Smart Cancer Patch that integrates AI-driven biosensors with a microfluidic drug delivery system for real-time monitoring, early detection, and localized treatment of multiple cancer types. By using biosensors to detect specific cancer biomarkers from sweat or saliva, the system sends the data to an AI system that predicts the likelihood of cancer development. The patch releases targeted drugs only if cancerous conditions are detected, thus offering a non-invasive and cost-effective method to address cancer risk. The patch also provides wireless connectivity to enable real-time data monitoring by medical professionals. This innovative combination of technology has the potential to transform the way cancer is detected, treated, and managed, improving outcomes for patients worldwide.